Related pages Drug Information Summaries Approval Process for New Cancer Treatments Access to Investigational Drugs: Q & A

This page contains brief information about docetaxel and a collection of links to more information from the National Cancer Institute (NCI), the Food and Drug Administration (FDA), and the National Library of Medicine (NLM).

US Brand Name(s):		Taxotere
FDA Approved:		Yes

Docetaxel is approved by the Food and Drug Administration (FDA) to be used alone or with other drugs to treat certain types of breast and non-small cell lung cancer (NSCLC). It is also approved to be used with other drugs to treat squamous cell carcinoma of the head and neck (SCCHN) and certain types of gastric and prostate cancer.

Docetaxel is being studied in the treatment of other types of cancer.

FDA Approval for Docetaxel - Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.

Clinical Trial Results: Taxane Combinations Marginally Better than Anthracyclines for Metastatic Breast Cancer (05/21/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Paclitaxel Versus Docetaxel for Early Breast Cancer (04/30/2008) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Trastuzumab Regimen Lessens Cardiac Side Effects (03/01/2006) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Frozen Glove Reduces Skin and Nail Damage from Docetaxel (08/01/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Docetaxel Combination for Node-Positive Breast Cancer (06/28/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Docetaxel Improves Survival in Stomach Cancer (05/15/2005) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Docetaxel an Alternative for Ovarian Cancer (11/23/2004) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: First Evidence That Chemotherapy Extends Life in Advanced Prostate Cancer (06/07/2004) - Important clinical trial results for this drug, background information, and how the trial was done.

Clinical Trial Results: Pemetrexed Is a Less Toxic Alternative for Recurrent Lung Cancer (06/12/2003) - Important clinical trial results for this drug, background information, and how the trial was done.

Two Types of Breast Cancer Treatments Show Similar Benefit (12/08/2005) - Information from the NCI Press Office about this drug.

MedlinePlus Information on Docetaxel - A lay language summary of important information about this drug that may include the following:

• warnings about this drug,
• what this drug is used for and how it is used,
• what you should tell your doctor before using this drug,
• what you should know about this drug before using it,
• other drugs that may interact with this drug, and
• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This NLM patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials for Docetaxel - Check for trials from NCI's PDQ Cancer Clinical Trials Registry now accepting patients.

Back to Top